Search Case Studies
Patients around the world with metal-on-metal hip replacements have benefited from UCL research that identified major problems with the implants.
UCL research has developed novel treatments for periodontitis, caries and other infectious diseases. These are quick, simple, and help to reduce antibiotic use.
The UCL Centre for Amyloidosis & Acute Phase Proteins has identified the cause and treatment for the prototypical cryopryin associated periodic syndrome (CAPS), and subsequently for a range of other hereditary and acquired autoinflammatory disorders.
Pioneering UCL research in the 1990s into the mechanisms that cause rheumatoid arthritis established a new understanding of the disease. As a result, a new treatment – B cell depletion – has been introduced worldwide.
The ATAC trial of a novel breast cancer treatment has resulted in a dramatic, global change in the management of the disease.
Target Medicine: inspiring and supporting applications to medical schools from non-selective state school students
Research conducted at UCL has underpinned the development of a free widening-participation programme for young people from non-selective state schools.
Biomedical engineers have developed an implant to lengthen limbs in young patients with bone cancers. It reduces the number of invasive surgeries patients require, cutting the risk of complications.
UCL research on oral health inequalities suggests an urgent need for a more evidence-based, integrated public health approach which has influenced both local and national policies and the development of clinical practice guidelines.
Research at UCL has transformed the breast cancer treatment paradigm so women can receive one-off radiation therapy focused to the tumour bed whilst undergoing a lumpectomy using the TARGIT technique.
Research at UCL on human haemolytic anaemias, known as the ‘hereditary stomatocytoses’, has improved diagnosis of these conditions, and has raised awareness of the potential impact on donated blood.